MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Net Income
-$1,013K
EPS
-$0.01
Unit: Thousand (K) dollars

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Sales - devices and disposables
0 559* 60 117
Cost of goods sold
0 102* 25 38
Gross profit
0 457 35 79
Research and development
45 126 136 133
Sales and marketing
23 23 22 51
General and administrative
451 1,018 362 658
Gain on remeasurement of deferred compensation conversion liability
217 NaN NaN NaN
Total operating expenses
302 1,167 520 842
Interest income
NaN NaN NaN 0
Loss from operations
-302 -710 -485 -763
Interest expense
151 184 129 157
Interest income
NaN 0* 0 NaN
Inducement charge for warrants issued
78 NaN NaN NaN
Change in fair value of derivative liability
13 76* -37 30
Gain from forgiveness of debt
3 51* 15 NaN
Loss on extinguishment of debt
0 -836* -106 0
Gain from forgiveness of debt
NaN NaN NaN 15
Other income
15 165* 0 NaN
Total other income (expense)
NaN NaN NaN -48
Total other income (expense)
-198 -729 -257 64
Loss before income taxes
-500 -1,216 -742 -811
Provision for income taxes
0 0 0 0
Net loss
-500 -1,216 -742 -811
Deemed dividend
510 NaN NaN NaN
Preferred stock dividends
3 26 43 45
Net loss attributable to common stockholders
-1,013 -1,242 -785 -856
Basic EPS
-0.01 -0.017 -0.01 -0.01
Diluted EPS
-0.01 -0.015 -0.01 -0.01
Basic Average Shares
88,836,000 75,139,000 81,689,000 NaN
Diluted Average Shares
88,836,000 84,838,000 81,689,000 78,838,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Net lossattributable to common...-$1,013K (-118.79%↓ Y/Y)Deemed dividend$510K Net loss-$500K (-17.10%↓ Y/Y)Preferred stock dividends$3K (-91.67%↓ Y/Y)Loss before incometaxes-$500K (-17.10%↓ Y/Y)Loss from operations-$302K (27.05%↑ Y/Y)Total other income(expense)-$198K (-302.04%↓ Y/Y)Other income$15K (-84.69%↓ Y/Y)Change in fair value ofderivative liability$13K (-75.00%↓ Y/Y)Gain fromforgiveness of debt$3K Total operatingexpenses$302K (-27.05%↓ Y/Y)Interest expense$151K (2.72%↑ Y/Y)Inducement charge forwarrants issued$78K Gain onremeasurement of deferred...$217K General andadministrative$451K (68.91%↑ Y/Y)Research and development$45K (-39.19%↓ Y/Y)Sales and marketing$23K (-68.49%↓ Y/Y)

GUIDED THERAPEUTICS INC (GTHP)

GUIDED THERAPEUTICS INC (GTHP)